Imaging of hypoxia in vivo helps with accurate cancer diagnosis and evaluation of therapeutic outcomes.A Pt II metallacage with oxygen-responsive red phosphorescence and steady fluorescence for in vivo hypoxia imaging and chemotherapyisreported. The therapeutic agent and diagnostic probe were integrated into the metallacage through heteroligation-directed self-assembly.N anoformulation by encapsulating the metallacage into nanoparticles greatly enhanced its stability the in physiological environment, rendering biomedical applications feasible.Apart from enhanced red phosphorescence upon hypoxia, the ratio between red and blue emissions,w hich only varies with intracellular oxygen level, provides am ore precise standardf or hypoxia imaging and detection. Moreover,i nvivo explorations demonstrate the promising potential applications of the metallacage-loaded nanoparticles as theranostic agents for tumor hypoxia imaging and chemotherapy.